Welcome to our dedicated page for Axis Cap Hldgs SEC filings (Ticker: AXS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
AXIS Capital Holdings Limited filings document the formal reporting record for a Bermuda-based specialty insurance and reinsurance company with common shares and Series E preferred depositary shares listed on the New York Stock Exchange. Its Form 8-K filings record operating results, investor financial supplements, Regulation FD presentations and securities-registration information for AXS and AXS PRE.
The company’s SEC disclosures also cover proxy governance, director elections, executive compensation, board and officer changes, equity awards and shareholder voting matters. Material-event filings describe subsidiary financing arrangements, including secured letter of credit facilities, along with related obligations, exhibits and capital-structure disclosures.
AXIS Capital (AXS) reported Q3 2025 results showing stronger underwriting and higher profitability. Net income was $301.9M versus $180.7M a year ago, and earnings per diluted share were $3.74 versus $2.04. Total revenues were $1.67B (from $1.61B).
Net premiums earned rose to $1.45B (from $1.37B). Underwriting income improved to $188.3M (from $135.2M) as the combined ratio fell to 89.4% (from 93.1%). Net investment income was $184.9M (vs. $205.1M), while net investment gains were $30.9M (vs. $32.2M). The quarter included foreign exchange gains of $13.5M.
Year to date, net income was $719.3M and the combined ratio was 89.5%. Operating cash flow for the first nine months was a use of $671.3M. Shareholders’ equity ended the quarter at $6.37B, aided by an AOCI swing to $10.2M. Common shares outstanding were 77,037,743 as of October 24, 2025.
AXIS Capital Holdings Limited furnished an 8-K announcing its third quarter 2025 results via a press release and an investor financial supplement, attached as Exhibit 99.1 and Exhibit 99.2.
The company stated these materials are furnished and not deemed “filed” under Section 18 of the Exchange Act. AXIS’s common shares trade on the NYSE under AXS, and depositary shares representing a 1/100th interest in its 5.50% Series E preferred shares trade as AXS PRE.
Henry B. Smith, a director of Axis Capital Holdings Ltd (AXS), reported a sale of common shares. On 08/21/2025 Mr. Smith sold 3,500 shares of AXS at a weighted average price of $98.67, with transaction prices in the range $98.47 to $98.83. Following the sale he beneficially owns 47,295 shares, held directly. The Form 4 was signed by G. Christina Gray-Trefry, Attorney-in-Fact, on 08/25/2025. The filer offers to provide a breakdown of shares sold at each separate price within the disclosed range upon request.
Daniel J. Draper, Group Chief Underwriting Officer and director of Axis Capital Holdings Ltd (AXS), reported the sale of 4,305 common shares on 08/20/2025 at a weighted-average price of $97.57 per share (trades ranged $97.22–$97.88). After the sale he beneficially owns 16,269 shares. The filing was signed by an attorney-in-fact on 08/21/2025. The report discloses the sale price range and notes Mr. Draper will provide details of shares sold at each price upon request.
Form 144 notice for proposed sale of securities by a holder of Axis Capital Holders Limited (AXS). The filing shows an intended sale of 3,500 common shares through Morgan Stanley Smith Barney LLC on 08/21/2025 with an aggregate market value of $345,338.35. The issuer olumns list 78,173,983 shares outstanding. The securities being sold were originally acquired as restricted stock vesting under a registered plan on 01/14/2011 (2,833 shares) and 01/30/2012 (667 shares), paid in cash at vesting. No sales by the same person are reported in the prior three months. The filer affirms they are not aware of undisclosed material adverse information about the issuer.
AXIS Capital Holdings Limited furnished an investor presentation that will be used in upcoming meetings with investors. The presentation has been filed as Exhibit 99.1 to this report and will also be available on the company’s investor website at www.investor.axiscapital.com.
The company states that the information in the presentation and in this report is being provided for informational purposes and is not considered "filed" under the securities laws unless specifically incorporated by reference in another filing. No new financial results, transactions, or strategic actions are detailed in this excerpt beyond the availability of the updated investor materials.
Form 144 filing by an insider for Axis Capital Holders Limited (AXS) discloses a proposed sale of 4,305 common shares through Morgan Stanley Smith Barney on the NYSE with an aggregate market value of $420,031.96 and approximately 78,173,983 shares outstanding. The filing records the acquisition source as restricted stock vesting under a registered plan: 1,041 shares vested 03/01/2024 and 3,264 shares vested 03/01/2025. Recent sales by the same person, Daniel Draper, are listed for August 15 and 19, 2025, totaling 4,400 shares across multiple transactions with gross proceeds shown per trade. The filer certifies no undisclosed material adverse information and includes the mandatory signature and legal notice regarding false statements.
Insider sales by Axis Capital director Daniel J. Draper. The filing reports Mr. Draper, Group Chief Underwriting Officer and a director, sold common shares of Axis Capital Holdings Ltd (AXS) on 08/15/2025 and 08/19/2025. He disposed of 2,200 shares on 08/15/2025 at a weighted-average price of $96.12 and another 2,200 shares on 08/19/2025 at $96.00. After these transactions he beneficially owned 20,574 shares. The filing discloses the weighted-average price range for the 08/15 sales as $95.78 to $96.52 and notes the seller will provide trade-level detail to the company, shareholders, or SEC staff on request.
Form 144 notice for Axis Capital Holders Limited (AXS): The filing reports a proposed sale of 2,200 common shares through Morgan Stanley Smith Barney on the NYSE with an aggregate market value of $211,200.00. The shares represent part of restricted stock that vested on 03/01/2024 (1,407 shares) and 03/01/2023 (793 shares). The filer previously sold the same 2,200 shares on 08/15/2025 in four transactions, producing combined gross proceeds of $211,463.78. The form includes the standard signer representation that no undisclosed material adverse information is known.
Form 144 notice for Axis Capital Holders Limited (AXS) reports a proposed sale of 2,200 common shares through Morgan Stanley Smith Barney LLC on the NYSE with an aggregate market value of $211,463.78. The filing states there are 78,173,983 shares outstanding, making the proposed sale a very small fraction of total shares.
The securities to be sold were acquired through restricted stock vesting under a registered plan on specific dates in 2022 and 2023, with lots of 8, 8, 1,075 and 1,109 shares respectively. The filer reports no securities sold in the past three months and represents they are not aware of undisclosed material adverse information about the issuer.